Blog
17 January 2023
How CANTAB can be used to overcome challenges in assessing cognition in people with intellectual disabilities
Operational scientist Eleanor Rist explores how CANTAB™ assessments can be beneficial for studies involving people with intellectual disabilities.
Read on
6 January 2023
Using CANTAB to assess cognitive function in long-term Hodgkin lymphoma survivors
We caught up with Dr Ferenc Magyari from the University of Debrecen, who told us how CANTABTM has helped them to understand the long-term cognitive impact of Hodgkin’s Lymphoma.
Read on
5 December 2022
2022 CANTAB Research Grant: Carotenoid uptake and cognitive and visual outcomes in Ghanaian schoolchildren
We caught up with the 2022 CANTABTM Research Grant Primary Award Winner, Nana Aba Senuwah Ashon, who tells us how the grant will help to understand the role of carotenoid uptake on vision and congition in Ghanaian schoolchildren.
Read on
25 November 2022
Emerging technology and other trends from SfN 2022
John Bernstein, Clinical Scientist at Cambridge Cognition, explores the trends and exciting developments that were discussed at the 2022 Society for Neuroscience (SfN) conference.
Read on
23 November 2022
Four key takeaways from our academic customer survey
In June 2022 we conducted a survey to find out more about what our academic customers think of Cambridge Cognition’s products and services. These surveys are a great opportunity for our customers to give us their honest and candid feedback. We had a great response and gained some very interesting insights and feedback. Here we discuss four of the main points that we learned from the survey.
Read on
3 November 2022
Remote Web-based Assessment of Cognition, Mood and Fatigue in People with Multiple Sclerosis
This poster was presented at ECTRIMS in October 2022.
Read on
18 October 2022
2022 CANTAB Research Grant: Assessing Chemotherapy-Related Cognitive Impairment (CRCI)
We caught up with 2022 CANTAB Research Grant winner Peter Mukli, who tells us about how the grant will enable him and his team to investigate the impact of chemotherapy on cognition in breast cancer survivors.
